Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral β-endorphin concentrations in premenstrual syndrome

Human Reproduction

Volumn 13, Issue 9, 1998, Pages 2402-2405

  Taskin, O ^a   Gokdeniz R ^a   Yalcinoglu, A ^a   Buhur, A ^a   Burak, F ^a   Atmaca, R ^a   Ozekici, U ^b  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Premenstrual syndrome; Therapy; Tibolone; endorphin

Indexed keywords

BETA ENDORPHIN; LIOTHYRONINE; THYROXINE; TIBOLONE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MENSTRUAL CYCLE; ORAL DRUG ADMINISTRATION; PREMENSTRUAL SYNDROME; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; THYROXINE BLOOD LEVEL;

EID: 0031705732     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.9.2402     Document Type: Article

References (25)

1. Aleem, F.A. and McIntosh, T. (1984) Elevated plasma levels of β-EP in a group of women with polycystic ovarian disease. Fertil Steril., 42, 686-689.
2. Carr, D.B., Bullen, B.A., Skrinar, G.S. et al. (1981) Physical conditioning facilitates the exercise-induced secretion of β-EP and β-lipotropin in women. N. Engl. J. Med., 305, 560-563.
3. Casson, P., Hahn, P.M., Van Vugt, D.A. and Reid, R.L. (1990) Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am. J. Obstet. Gynecol., 162, 99-105.
4. Chuong, C.J., Coulam, C.B., Kao, P.C. et al. (1985) Neuropeptide levels in premenstrual syndrome. Fertil. Steril., 44, 760-765.
5. Chuong, C.J., Smith, E.R. and Tsong, Y. (1989) β-EP levels in the human menstrual cycle. Acta Obstet. Gynecol. Scand., 68, 497-501.
6. Chuong, C.J., Kim, S.R., Taskin, O. and Karacan, I. (1997) Sleep pattern changes in menstrual cycles of women with premenstrual syndrome: a preliminary study. Am. J. Obstet. Gynecol., 177, 554-558.
7. Cohen, M.R., Cohen, R.M., Pickar, D. et al. (1981) Behaviour effects after high dose naloxone administration to normal volunteers. Lancet, 2, 1110.
8. Dye, L. and Blundell, J.E. (1997) Menstrual cycle and appetite control: implications for weight regulation. Hum. Reprod., 12, 1142-1151.
9. Facchinetti, F., Martignoni, E., Petraglia, F. et al. (1987) Premenstrual fall of plasma β-EP in patients with premenstrual syndrome. Fertil. Steril., 47, 570-573.
10. Frank, R.T. (1931) The hormonal causes of premenstrual tension. Arch. Neurol. Psychiatr., 26, 1053-1057.
11. Frederickson, R.C.A. and Geary, L.E. (1982) Endogenous opioid peptides: review of physiological, pharmacological and clinical aspects. Prog. Neurobiol., 19, 19-69.
12. Genazzani, A.R., Facchinetti, F., Pintor, C. et al. (1983) Proopiomelanocortin-related peptide plasma levels throughout puberty and prepuberty. J. Clin. Endocrinol. Metab., 57, 56-61.
13. Genazzani, A.R., Petraglia, F., Facchinetti, F. et al. (1987) Effects of Org OD 14 on pituitary and peripheral β-endorphin in castrated rats and postmenopausal women. Maturitas, 9 (Suppl. 1), 35-48.
14. Haenggi, W., Riesen, W. and Birkhaeuser, M.H. (1993) Postmenopausal hormone replacement therapy with Tibolone decreases serum lipoprotein(a). Eur. J. Clin. Chem. Clin. Biochem., 31, 645-650.
15. Halbreich, U., Endicott, J. and Nee, J. (1983) Premenstrual depressive changes: value of differentiation. Arch. Gen. Psychiatr., 40, 535-542.
16. Haskett, R.F. and Abplanalp, J.M. (1983) Premenstrual tension syndrome: diagnostic criteria and selection of research subjects. Psychiatry Res., 9, 125-138.
17. Lewis, L.L., Greenblatt, E.M., Rittenhouse, C.A. et al. (1995) Pulsatile release patterns of luteinizing hormone and progesterone in relation to symptom onset in women with premenstrual syndrome. Fertil. Steril., 64, 288-292.
18. Lindsay, R., Hart, D.M. and Kraszewski, A. (1989) Prospective randomized trial of synthetic steroid (ORG OD 14) for preventing post-menopausal osteoporosis. Br. Med. J., 280, 1207-1209.
19. Mezrow, G., Shoupe, D., Spicer, D. et al. (1994) Depot Leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril., 62, 932-937.
20. O'Donohue, T.L. and Dorsa, D.M. (1982) The proopiomelanotropinergic neuronal and endocrine system. Peptides, 3, 353-395.
21. Reid, R.L. and Yen, S.S.C. (1981) Premenstrual syndrome. Am. J. Obstet. Gynecol., 139, 85-104.
22. Seifer, D.B. and Collins, R.L. (1990) Current concepts of β-EP physiology in female reproductive dysfunction. Fertil. Steril., 54, 757-771.
23. Steiner, M., Haskett, R.F. and Caroll, B.J. (1980) Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr. Scand., 62, 177-190.
24. Trevoux, R., Dieulangard, P. and Blum, A. (1983) Efficacy and safety of ORG Op 14 in the treatment of climacteric complaints. Maturitas, 5, 86-96.
25. Tulenheimo, A. and Laatikainen, S.K. (1987) Plasma β-EP immunoreactivity in premenstrual tension. Br. J. Obstet. Gynaecol., 94, 26-29.